Dashboard
Manage Tickers

PHAT


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

needham-reiterates-buy-on-phathom-pharmaceuticals-maintains-26-price-target
Needham Reiterates Buy on Phathom Pharmace...
09/06/2024 17:14:34

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

needham-reiterates-buy-on-phathom-pharmaceuticals-maintains-26-price-target
Needham Reiterates Buy on Phathom Pharmace...
08/30/2024 16:07:34

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

needham-reiterates-buy-on-phathom-pharmaceuticals-maintains-26-price-target
Needham Reiterates Buy on Phathom Pharmace...
08/23/2024 17:20:14

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

phathom-pharmaceuticals-prices-offering-of-87m-shares-and-26m-pre-funded-warrants-at-1150-per-share-raising-approximately-130m
Phathom Pharmaceuticals Prices Offering Of...
08/19/2024 12:02:50

needham-reiterates-buy-on-phathom-pharmaceuticals-maintains-26-price-target
Needham Reiterates Buy on Phathom Pharmace...
08/19/2024 09:37:24

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

hc-wainwright--co-reiterates-buy-on-phathom-pharmaceuticals-maintains-28-price-target
HC Wainwright & Co. Reiterates Buy on Phat...
08/12/2024 10:00:51

HC Wainwright & Co. analyst Matthew Caufield reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $...

needham-reiterates-buy-on-phathom-pharmaceuticals-maintains-26-price-target
Needham Reiterates Buy on Phathom Pharmace...
08/12/2024 09:48:52

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

goldman-sachs-maintains-neutral-on-phathom-pharmaceuticals-raises-price-target-to-12
Goldman Sachs Maintains Neutral on Phathom...
08/09/2024 15:49:48

Goldman Sachs analyst Paul Choi maintains Phathom Pharmaceuticals (NASDAQ:PHAT) with a Neutral and raises the price target f...

as-of-june-30-2024-phathom-pharmaceuticals-cash-and-cash-equivalents-were-2762m--the-company-believes-it-will-have-sufficient-capital-to-fund-operations-through-the-end-of-2026
As Of June 30, 2024, Phathom Pharmaceutica...
08/08/2024 12:07:51

phathom-pharmaceuticals-q2-2024-adj-eps-125-beats-138-estimate-sales-7324m-beat-5809m-estimate
Phathom Pharmaceuticals Q2 2024 Adj. EPS $...
08/08/2024 12:06:31

Core News & Articles
CVS Caremark Adds VOQUEZNA Tablets To Nati...
07/30/2024 12:11:18

Now Accessible To Over 116M Commercially Covered Lives; First FDA-Approved PCAB For GERD Treatment In Over 30 Years, Says Phath...

needham-reiterates-buy-on-phathom-pharmaceuticals-maintains-26-price-target
Needham Reiterates Buy on Phathom Pharmace...
07/26/2024 10:22:01

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

needham-reiterates-buy-on-phathom-pharmaceuticals-maintains-26-price-target
Needham Reiterates Buy on Phathom Pharmace...
07/22/2024 12:20:14

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

hc-wainwright--co-reiterates-buy-on-phathom-pharmaceuticals-maintains-28-price-target
HC Wainwright & Co. Reiterates Buy on Phat...
07/19/2024 10:41:33

HC Wainwright & Co. analyst Matthew Caufield reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $...

needham-reiterates-buy-on-phathom-pharmaceuticals-maintains-26-price-target
Needham Reiterates Buy on Phathom Pharmace...
07/19/2024 09:48:13

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

the-fda-approved-phathom-pharmaceuticals-voquezna-vonoprazan-10-mg-tablets-for-heartburn-associated-with-non-erosive-gastroesophageal-reflux-disease-in-adults-this-is-the-third-fda-approval-for-voquezna
The FDA Approved Phathom Pharmaceuticals' ...
07/18/2024 12:10:42

needham-reiterates-buy-on-phathom-pharmaceuticals-maintains-26-price-target
Needham Reiterates Buy on Phathom Pharmace...
07/12/2024 12:56:57

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

needham-reiterates-buy-on-phathom-pharmaceuticals-maintains-26-price-target
Needham Reiterates Buy on Phathom Pharmace...
07/08/2024 10:20:38

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

needham-reiterates-buy-on-phathom-pharmaceuticals-maintains-26-price-target
Needham Reiterates Buy on Phathom Pharmace...
06/28/2024 15:02:23

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

needham-reiterates-buy-on-phathom-pharmaceuticals-maintains-26-price-target
Needham Reiterates Buy on Phathom Pharmace...
06/21/2024 14:05:24

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION